首页> 外文OA文献 >Plant stanol esters and blood cholesterol ‐ Scientific substantiation of a health claim related to plant stanol esters and lower/reduced blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006 ‐ Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

【2h】

Plant stanol esters and blood cholesterol ‐ Scientific substantiation of a health claim related to plant stanol esters and lower/reduced blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006 ‐ Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies

机译：植物甾烷酯和血液胆固醇 - 科学证实与植物甾烷醇酯和较低/降低的血液胆固醇有关的健康权利要求，并根据第1924/2006第14条 - 科学意见（EC）第14条 - 科学意见减少（冠状动脉患者心脏病的风险饮食产品，营养和过敏委员会

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Response to comments on the Scientific Opinion of the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) on the modification of the authorisation of a health claim related to plant sterol esters and lowering blood LDL‐cholesterol; high blood LDL‐cholesterol is a risk factor in the development of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006, following a request in accordance with Article 19 of Regulation (EC) No 1924/2006 [J] . EFSA supporting publications . 2014,第5期

机译：对欧洲食品安全局（EFSA）的营养产品，营养和过敏委员会（NDA）关于修改与植物固醇酯和降低血液中LDL-胆固醇有关的健康声明授权的科学意见的评论的回应;依照（EC）1924/2006号法规第19条的要求，根据（EC）1924/2006号法规第14条，高血LDL-胆固醇是导致（冠状动脉）心脏病发展的危险因素
2. Response to comments on the Scientific Opinion on the substantiation of a health claim related to 3 g/day plant stanols as plant stanol esters and lowering blood LDL‐cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006 [J] . EFSA supporting publications . 2012,第9期

机译：根据法规（EC）第14条对关于以3 g /天的植物甾烷醇作为植物甾烷醇酯和降低血液中LDL-胆固醇和降低（冠心病）心脏病风险的科学主张的科学意见的评论的回应No 1924/2006
3. Scientific Opinion on the substantiation of a health claim related to 3 g/day plant stanols as plant stanol esters and lowering blood LDL‐cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006 [J] . EFSA Journal . 2012,第5期

机译：关于根据1924/2006号法规（EC）第14条以每天3 g植物甾烷醇作为植物甾烷醇酯和降低血液中LDL-胆固醇和降低（冠状动脉）心脏病风险的健康主张的科学意见
4. Symbiosal® and lowering of blood pressure and reduced risk of hypertension: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 [O] . EFSA Panel on Dietetic Products, Nutrition and Allergies (EFSA NDA Panel), Dominique Turck, 2018

机译：Symbiosal®和降低血压降低高血压风险：根据（EC）1924/2006号法规第14条评估健康声明
5. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of a health claim related to 3 g/day plant stanols as plant stanol esters and lowering blood LDL-cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006 [O] . Tetens Inge 2012

机译：EFsa饮食产品，营养和过敏专家组（NDa）;关于根据第（EC）1924/2006号条例第14条证实与3克/天植物甾烷醇作为植物甾烷醇酯并降低血液LDL-胆固醇和降低（冠心病）心脏病风险的健康声明的科学意见

著录项

引文网络

相似文献

相关主题

期刊订阅